Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Triage Your Portfolio With Abbott Laboratories

By Dana Blankenhorn, InvestorPlace Contributor

ABT stock is trading at pre-pandemic levels thanks to strong earnings and a new test for coronavirus antibodies that's garnering attention.

Johnson & Johnson Stock Is Your Shelter From the Storm

By Dana Blankenhorn, InvestorPlace Contributor

Last year, investors saw JNJ stock as a laggard in the pharma space. Now it has stellar earnings and a promising coronavirus candidate.

Buying Gilead Sciences Stock Means Buying Into Political Risk

By Dana Blankenhorn, InvestorPlace Contributor

GILD stock is rising on Gilead's potential coronavirus cure. But Gilead also has a questionable past, and it faces worrying patent disputes.

Analysts All Love eBay Stock, But It’s Not a Buy Here

By Dana Blankenhorn, InvestorPlace Contributor

eBay stock may finally have things pointed in the right direction, and analysts are pounding the table for it. But we've heard this before.

Moderna Stock Is the Greatest Coronavirus Speculation Play

By Dana Blankenhorn, InvestorPlace Contributor

Moderna was able to quickly develop a vaccine candidate because Covid-19 is similar to MERS, which it had been working on for two years.

JPMorgan Chase Stock Is Worth A Look Under One Condition

By Dana Blankenhorn, InvestorPlace Contributor

JPMorgan Chase was able to get through the 2008 banking crisis stronger than before. But the coronavirus pandemic is showing its systems can't keep up with demands for new money.

Amazon Is Still Strangling FedEx Stock

By Dana Blankenhorn, InvestorPlace Contributor

FedEx founder and CEO Fred Smith takes the fight with Amazon personally, while UPS treats it as yet another corporate challenge.

You Can’t Bet on Chevron Stock’s Dividend Right Now

By Dana Blankenhorn, InvestorPlace Contributor

Chevron stock was prepared for trouble on oil prices this year, but the coronavirus is wiping out even those pessimistic estimates.

The Bullish Case for Nio Stock Is Greatly Misguided

By Dana Blankenhorn, InvestorPlace Contributor

Nio was bailed-out by the government of Hefei, home of state-owned JAC Motors, putting it in the mainstream of Chinese electric car development.

Exxon Mobil Could Win the Price Battle, But It Will Lose the Energy War

By Dana Blankenhorn, InvestorPlace Contributor

The oil price war isn't the temporary problem Exxon Mobil stock bulls think it is. It's a permanent change in how the world works.

Load More